The invention provides a method and a detection kit for identifying a biomarker of
cerebral infarction. The biomarker is free
mannose and glucose obtained by
high performance liquid chromatography based on pre-column 1-phenyl-3-methyl-5-
pyrazolone (PMP)
derivatization in serum. The detection method is the
high performance liquid chromatography method based on the pre-column PMP
derivatization. Thetechnical scheme has the advantages that the pretreatment is simple, the analysis time is short, the instrument price is reasonable, the requirements of conventional use are met, the operation stepsare simple and easy to learn, the accuracy of a detection result is high, a normal person and a
cerebral infarction patient can be distinguished only by
blood collection, the amount of the needed serum is extremely small, the
blood collection amount is smaller than 1 mL, and the like. The obtained result shows that the
analysis method can be used for rapidly determining the content of the free
mannose and glucose in the serum of the
cerebral infarction patient, so that the method has very important significance for researching a relation between the free
mannose and glucose in the serum and the cerebral
infarction, and looking for a novel cerebral
infarction clinical detection marker.